“Bladder Cancer Diagnosis and Monitoring Based on Urine Survivin (BIRC5) Bioluminescence-Based Immunoassay”. 2026. Voprosy Onkologii 72 (2): OF-2510. https://doi.org/10.37469/0507-3758-2026-72-2-OF-2510.